Ima Arum Lestarini
Department of Medical, Faculty of Medical, Universitas Mataram, Mataram, Indonesia

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

Antibacterial Sulfonated Hydroxyxanthone Derivatives: Synthesis, In Vitro Evaluation, and Molecular Docking Studies Emmy Yuanita; Zuriatun Toyyibah; Maulida Septiyana; Ni Komang Tri Dharmayani; Baiq Ike Nursofia; Ima Arum Lestarini; Faris Hermawan; Baiq Nila Sari Ningsih
Indonesian Journal of Chemical Research Vol 14 No 2 (2026): Edition for September 2026
Publisher : Jurusan Kimia, Fakultas Sains dan Teknologi, Universitas Pattimura

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30598/ijcr.2026.14-emm

Abstract

The emergence of antibiotic resistance and the declining drug effectiveness make it imperative to identify potential drug candidates. This study aims to synthesize hydroxyxanthone derivatives as antibacterial candidates. Activity tests were carried out in vitro using Staphylococcus aureus and Escherichia coli, and in silico using molecular docking. Sulfonated hydroxyxanthone derivatives (2a and 2b) were synthesized from 1,3,7- and 1,3,6-trihydroxyxanthones (1a and 1b) through the sulfonation method, yielding 41% and 44%, respectively. The compounds showed greater efficacy against Escherichia coli, with maximum inhibition zones of 14.33 mm (1a) and 15.00 mm (1b), while the sulfonated compound 2b showed relatively better activity against Staphylococcus aureus with an inhibition zone of 14.00 mm, highlighting the impact of molecular structure on antibacterial performance. Molecular docking analysis against penicillin-binding protein 1A (PBP1A) revealed that sulfonated compounds (2a and 2b) exhibited the lowest binding affinity (−7.9 kcal/mol), stronger than the native ligand (penicillin G, -7.4 kcal/mol) and the positive control (amoxicillin, −7.7 kcal/mol), with key interactions with residues Ser487, Thr670, and Thr672, indicating high complex stability and potential inhibitory activity against PBP1A.